The pharmaceutical industry stands at the cusp of a paradigm shift fueled by the transformative power of artificial intelligence (AI). Conventional drug discovery processes are notoriously protracted, demanding significant expenditure. AI-powered tools offer a promising solution by automating key stages, from target identification and drug design t